Avanos Medical (AVNS) Equity Average (2013 - 2026)

Avanos Medical's Equity Average history runs 14 years deep, the most recent figure standing at $780.2 million for Q1 2026.

• In Q1 2026, Equity Average rose 110.74% year-over-year to $780.2 million; the TTM figure through Mar 2026 stood at $780.2 million (up 110.74% YoY), while the FY2025 annual figure was $339.6 million, down 40.28% from the prior year.
• Equity Average came in at $780.2 million for Q1 2026 at Avanos Medical, roughly flat from $778.1 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $1.6 billion in Q2 2022 to a low of -$314.9 million in Q2 2024.
• A 5-year average of $710.2 million and a median of $575.8 million in 2023 frame the typical range for Equity Average.
• Across the five-year window, Equity Average sank 518.66% in 2024 and jumped 228.2% in 2025, its largest moves.
• Avanos Medical's Equity Average stood at $1.3 billion in 2022, then slipped by 3.77% to $1.2 billion in 2023, then slumped by 54.01% to $565.4 million in 2024, then soared by 37.63% to $778.1 million in 2025, then grew by 0.26% to $780.2 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $780.2 million, $778.1 million, and $373.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison